MOBILIZE, NCT06290128: A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work |
|
|
| Recruiting | 3 | 140 | US | Riliprubart, SAR445088, Placebo | Sanofi | Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic | 02/26 | 10/27 | | |
VITALIZE, NCT06290141: A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
|
|
| Recruiting | 3 | 160 | US | riliprubart, SAR445088, Placebo, IVIg, IVIg premedication | Sanofi | Chronic Inflammatory Demyelinating Polyneuropathy | 11/25 | 05/27 | | |
